Analysts expect Puma Biotechnology, Inc. (NASDAQ:PBYI) to report $-0.72 EPS on May, 9.They anticipate $1.25 EPS change or 63.45% from last quarter’s $-1.97 EPS. After having $-1.71 EPS previously, Puma Biotechnology, Inc.’s analysts see -57.89% EPS growth. The stock decreased 3.09% or $2 …
0 Comments